Exscientia's Bold Leap Forward in AI-Driven PharmaIntroduction: A Turbulent Turnaround
Exscientia plc (NASDAQ: EXAI), a pioneering force in AI-driven pharmaceuticals, recently faced a storm that tested its core. Amidst leadership controversies, the company has not just weathered the storm but is poised for a transformative leap, signaling a potent
